Hedgehog signaling pathway as key player in liver fibrosis: New insights and perspectives

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 9, 2014, Pages 1011-1021

  Yang, Jing Jing ^a   Tao, Hui ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Extracellular matrix; Hedgehog signaling pathway; Hepatic stellate cell; Liver fibrosis; MicroRNA

Indexed keywords

METHYL CPG BINDING PROTEIN 2; MICRORNA; SONIC HEDGEHOG PROTEIN; BIOLOGICAL MARKER;

CELL ACTIVATION; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; DNA METHYLATION; HUMAN; IRRADIATION; LIVER FIBROSIS; METABOLISM; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; ANIMAL; DRUG DESIGN; LIVER CIRRHOSIS; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG DESIGN; HEDGEHOG PROTEINS; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION;

EID: 84906264574     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.927443     Document Type: Review

References (118)

1. Motawi TM, Atta HM, Sadik NA, Azzam M. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis. Cell Biochem Biophys 2014;68(1):111-25
2. Yang JJ, Tao H, Huang C, Li J. Nuclear erythroid 2-related factor 2: a novel potential therapeutic target for liver fibrosis. Food Chem Toxicol 2013;59:421-7
3. Tao H, Yang JJ, Shi KH, et al. The significance of YKL-40 protein in liver fibrosis. Inflamm Res 2014;63(4):249-54
4. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-69
5. Lamireau T, Desmouliere A, Bioulac-Sage P, Rosenbaum J. [Mechanisms of hepatic fibrogenesis]. Arch Pediatr 2002;9:392-405
6. Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol 2011;25:195-206
7. Nevzorova YA, Hu W, Cubero FJ, et al. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis. Biochim Biophys Acta 2013;1832:1765-75
8. Freise C, Erben U, Muche M, et al. The alpha 2 chain of collagen type VI sequesters latent proforms of matrixmetalloproteinases and modulates their activation and activity. Matrix Biol 2009;28:480-9
9. Maria ZE, Luca N, Gianluca S, et al. Hepatic PPARs: their role in liver physiology, fibrosis and treatment. Curr Med Chem 2013;20(27):3370-96
10. Cheng C, Huang C, Ma TT, et al. New surprises of suppressor of cytokine signalling in liver fibrosis. Expert Opin Ther Targets 2014;18(4):415-26
11. Liu Y, Wang Z, Kwong SQ, et al. Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib. J Hepatol 2011;55:612-25
12. Ghiassi-Nejad Z, Hernandez-Gea V, Woodrell C, et al. Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury. Hepatology 2013;57:786-96
13. Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol 2011;6:425-56
14. Osawa Y, Hoshi M, Yasuda I, et al. Tumor necrosis factor-alpha promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS One 2013;8:e65251
15. Paris AJ, Snapir Z, Christopherson CD, et al. A polymorphism that delays fibrosis in hepatitis C promotes alternative splicing of AZIN1, reducing fibrogenesis. Hepatology 2011;54:2198-207
16. He Y, Huang C, Lin X, Li J. MicroRNA-29 family, a crucial therapeutic target for fibrosis diseases. Biochimie 2013;95:1355-9
17. Zhou Y, Zheng S, Lin J, et al. The interruption of the PDGF and EGF signaling pathways by curcumin stimulates gene expression of PPARgamma in rat activated hepatic stellate cell in vitro. Lab Invest 2007;87:488-98
18. Kuo JJ, Wang CY, Lee TF, et al. Paeoniae radix reduces PDGF-stimulated hepatic stellate cell migration. Planta Med 2012;78:341-8
19. Lopez-Navarrete G, Ramos-Martinez E, Suarez-Alvarez K, et al. Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation. Int J Biol Sci 2011;7:1273-86
20. Pereira Tde A, Witek RP, Syn WK, et al. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma. Lab Invest 2010;90:1690-703
21. Mfopou JK, De Groote V, Xu X, et al. Sonic hedgehog and other soluble factors from differentiating embryoid bodies inhibit pancreas development. Stem Cells 2007;25:1156-65
22. Philips GM, Chan IS, Swiderska M, et al. Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer. PLoS ONE 2011;6:e23943
23. Kim HY, Cho HK, Hong SP, Cheong J. Hepatitis B virus X protein stimulates the Hedgehog-Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells. Cancer Lett 2011;309:176-84
24. Calvisi DF, Frau M, Tomasi ML, et al. Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: novel insights from interspecies comparison. Biochim Biophys Acta 2012;1826:215-37
25. Omenetti A, Bass LM, Anders RA, et al. Hedgehog activity, epithelialmesenchymal transitions, and biliary dysmorphogenesis in biliary atresia. Hepatology 2011;53:1246-58
26. Olsen AL, Bloomer SA, Chan EP, et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol 2011;301:G110-18
27. Chu PS, Nakamoto N, Ebinuma H, et al. C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice. Hepatology 2013;58:337-50
28. Bai T, Lian LH, Wu YL, et al. Thymoquinone attenuates liver fibrosis via PI3K and TLR4 signaling pathways in activated hepatic stellate cells. Int Immunopharmacol 2013;15:275-81
29. van der Vliet A, Bove PF. Purinergic signaling in wound healing and airway remodeling. Subcell Biochem 2011;55:139-57
30. Mak KM, Chu E, Lau KH, Kwong AJ. Liver fibrosis in elderly cadavers: localization of collagen types I, III, and IV, alpha-smooth muscle actin, and elastic fibers. Anat Rec (Hoboken) 2012;295:1159-67
31. Manousou P, Burroughs AK, Sochatzis ET, et al. Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation. J Hepatol 2013;58:962-8
32. Veidal SS, Nielsen MJ, Leeming DJ, Karsdal MA. Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model. BMC Res Notes 2012;5:686
33. Oakley F, Teoh V, Ching ASG, et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 2009;136:2334-44. e1
34. Xue ZF, Wu XM, Liu M. Hepatic regeneration and the epithelial to mesenchymal transition. World J Gastroenterol 2013;19:1380-6
35. Bi WR, Yang CQ, Shi Q. Transforming growth factor-beta1 induced epithelialmesenchymal transition in hepatic fibrosis. Hepatogastroenterology 2012;59:1960-3
36. Chu AS, Diaz R, Hui JJ, et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 2011;53:1685-95
37. Wang FP, Li L, Li J, et al. High mobility group box-1 promotes the proliferation and migration of hepatic stellate cells via TLR4-dependent signal pathways of PI3K/Akt and JNK. PLoS One 2013;8:e64373
38. Tacke F, Weiskirchen R. Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques. Expert Rev Gastroenterol Hepatol 2012;6:67-80
39. Wei J, Feng L, Li Z, et al. MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling. Biomed Pharmacother 2013;67:387-92
40. He Y, Huang C, Zhang SP, et al. The potential of microRNAs in liver fibrosis. Cell Signal 2012;24:2268-72
41. Meurer SK, Alsamman M, Sahin H, et al. Overexpression of endoglin modulates TGF-beta1-signalling pathways in a novel immortalized mouse hepatic stellate cell line. PLoS One 2013;8:e56116
42. Kastanis GJ, Hernandez-Nazara Z, Nieto N, et al. The role of dystroglycan in PDGF-BB-dependent migration of activated hepatic stellate cells/ myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2011;301:G464-74
43. Li X, Wang X, Han C, et al. Astragaloside IV suppresses collagen production of activated hepatic stellate cells via oxidative stress-mediated p38 MAPK pathway. Free Radic Biol Med 2013;60:168-76
44. Su LJ, Chang CC, Yang CH, et al. Graptopetalum paraguayense ameliorates chemical-induced rat hepatic fibrosis in vivo and inactivates stellate cells and Kupffer cells in vitro. PLoS One 2013;8:e53988
45. Brunati AM, Pagano MA, Bindoli A, Rigobello MP. Thiol redox systems and protein kinases in hepatic stellate cell regulatory processes. Free Radic Res 2010;44:363-78
46. Lee LY, Kaizu T, Toyokawa H, et al. Carbon monoxide induces hypothermia tolerance in Kupffer cells and attenuates liver ischemia/reperfusion injury in rats. Liver Transpl 2011;17:1457-66
47. Yang J, Zheng J, Wu L, et al. NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One 2011;6:e27710
48. Wang JJ, Huan SK, Hsieh KH, et al. Inhibitory effect of midazolam on MMP- 9, MMP-1 and MMP-13 expression in PMA-stimulated human chondrocytes via recovery of NF-kappaB signaling. Arch Med Sci 2013;9:332-9
49. Ohyama T, Yamazaki Y, Sato K, et al. Transforming growth factor-alpha attenuates hepatic fibrosis: possible involvement of matrix metalloproteinase-1. Liver Int 2011;31:572-84
50. Szuster-Ciesielska A, Mizerska-Dudka M, Daniluk J, Kandefer-Szerszen M. Butein inhibits ethanol-induced activation of liver stellate cells through TGF-beta, NFkappaB, p38, and JNK signaling pathways and inhibition of oxidative stress. J Gastroenterol 2013;48:222-37
51. Domitrovic R, Jakovac H, Marchesi VV, Blazekovic B. Resolution of liver fibrosis by isoquinoline alkaloid berberine in CCl4-intoxicated mice is mediated by suppression of oxidative stress and upregulation of MMP-2 expression. J Med Food 2013;16:518-28
52. Ikebuchi Y, Ishida C, Okamoto K, Murawaki Y. Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type c chronic liver disease. Biochem Genet 2013;51(7-8):564-74
53. Martin IV, Borkham-Kamphorst E, Zok S, et al. Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis. Am J Pathol 2013;182:107-17
54. Ramani K, Yang H, Kuhlenkamp J, et al. Changes in the expression of methionine adenosyltransferase genes and S-adenosylmethionine homeostasis during hepatic stellate cell activation. Hepatology 2010;51:986-95
55. Yang Q, Liu HY, Zhang YW, et al. Anandamide induces cell death through lipid rafts in hepatic stellate cells. J Gastroenterol Hepatol 2010;25:991-1001
56. Tang Y, Hu C, Liu Y. Effect of bioactive peptide of Carapax Trionycis on TGF-beta1-induced intracellular events in hepatic stellate cells. J Ethnopharmacol 2013;148:69-73
57. Kong D, Zhang F, Wei D, et al. Paeonol inhibits hepatic fibrogenesis via disrupting nuclear factor-kappaB pathway in activated stellate cells: in vivo and in vitro studies. J Gastroenterol Hepatol 2013;28:1223-33
58. Omenetti A, Choi S, Michelotti G, Diehl AM. Hedgehog signaling in the liver. J Hepatol 2011;54:366-73
59. Peng Y, Yang H, Zhu T, et al. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways. Eur J Clin Invest 2013;43:358-68
60. Merchant JL, Saqui-Salces M, El-Zaatari M. Hedgehog signaling in gastric physiology and cancer. Prog Mol Biol Transl Sci 2010;96:133-56
61. Wang XL, Zhao YS, Hu MY, et al. Umbilical cord blood cells regulate endogenous neural stem cell proliferation via hedgehog signaling in hypoxic ischemic neonatal rats. Brain Res 2013;1518:26-35
62. Chen JS, Huang XH, Wang Q, et al. Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. Carcinogenesis 2013;34:10-19
63. Liu CF, Breidenbach A, Aschbacher-Smith L, et al. A role for hedgehog signaling in the differentiation of the insertion site of the patellar tendon in the mouse. PLoS One 2013;8:e65411
64. Briscoe J, Therond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol 2013;14:418-31
65. Bhave VS, Mars W, Donthamsetty S, et al. Regulation of liver growth by glypican 3, CD81, hedgehog, and hhex. Am J Pathol 2013;183:153-9
66. Gotschel F, Berg D, Gruber W, et al. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehogtarget genes and stabilized expression of GLI1. PLoS One 2013;8:e65403
67. Walton KD, Kolterud A, Czerwinski MJ, et al. Hedgehog-responsive mesenchymal clusters direct patterning and emergence of intestinal villi. Proc Natl Acad Sci USA 2012;109:15817-22
68. Zhang S, Wang Y, Mao JH, et al. Inhibition of CK2alpha down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells. PLoS One 2012;7:e38996
69. Pimentel A, Velez M, Barahona LJ, et al. New prospects for drug development: the hedgehog pathway revealed. Focus on hematologic malignancies. Future Oncol 2013;9:681-97
70. Shi D, Lv X, Zhang Z, et al. Smoothened oligomerization/higher order clustering in lipid rafts is essential for high Hedgehog activity transduction. J Biol Chem 2013;288:12605-14
71. Ruiz i Altaba A. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases. Sci Signal 2011;4:pt9
72. Saqui-Salces M, Merchant JL. Hedgehog signaling and gastrointestinal cancer. Biochim Biophys Acta 2010;1803:786-95
73. Ruch JM, Kim EJ. Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs 2013;73:613-23
74. Zeng H, Jia J, Liu A. Coordinated translocation of mammalian Gli proteins and suppressor of fused to the primary cilium. PLoS One 2010;5:e15900
75. Pan JY, Zhou SH. The hedgehog signaling pathway, a new therapeutic target for treatment of ischemic heart disease. Pharmazie 2012;67:475-81
76. Bowers M, Eng L, Lao Z, et al. Limb anterior-posterior polarity integrates activator and repressor functions of GLI2 as well as GLI3. Dev Biol 2012;370:110-24
77. Drakopoulou E, Outram SV, Rowbotham NJ, et al. Non-redundant role for the transcription factor Gli1 at multiple stages of thymocyte development. Cell Cycle 2010;9:4144-52
78. Caparros-Martin JA, Valencia M, Reytor E, et al. The ciliary Evc/ Evc2 complex interacts with Smo and controls Hedgehog pathway activity in chondrocytes by regulating Sufu/ Gli3 dissociation and Gli3 trafficking in primary cilia. Hum Mol Genet 2013;22:124-39
79. McMillan R, Matsui W. Molecular pathways: the hedgehog signaling pathway in cancer. Clin Cancer Res 2012;18:4883-8
80. Chaudary N, Pintilie M, Hedley D, et al. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation. Cancer 2012;118:3105-15
81. Das S, Samant RS, Shevde LA. Nonclassical activation of hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to Smoothened-targeting hedgehog inhibition. J Biol Chem 2013;288:11824-33
82. Yang L, Wang Y, Mao H, et al. Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells. J Hepatol 2008;48:98-106
83. Choi SS, Syn WK, Karaca GF, et al. Leptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway. J Biol Chem 2010;285:36551-60
84. Swiderska-Syn M, Syn WK, Xie G, et al. Myofibroblastic cells function as progenitors to regenerate murine livers after partial hepatectomy. Gut 2013. [Epub ahead of print]
85. Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol Gastrointest Liver Physiol 2009;297:G1093-106
86. Michelotti GA, Xie G, Swiderska M, et al. Smoothened is a master regulator of adult liver repair. J Clin Invest 2013;123(6):2380-94
87. Omenetti A, Syn WK, Jung Y, et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 2009;50:518-27
88. Choi SS, Witek RP, Yang L, et al. Activation of Rac1 promotes hedgehogmediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology 2010;52:278-90
89. Che L, Yuan YH, Jia J, Ren J. Activation of sonic hedgehog signaling pathway is an independent potential prognosis predictor in human hepatocellular carcinoma patients. Chin J Cancer Res 2012;24:323-31
90. Syn WK, Witek RP, Curbishley SM, et al. Role for hedgehog pathway in regulating growth and function of invariant NKT cells. Eur J Immunol 2009;39:1879-92
91. Pritchett J, Harvey E, Athwal V, et al. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology 2012;56:1108-16
92. Syn WK, Agboola KM, Swiderska M, et al. NKT-associated hedgehog and osteopontin drive fibrogenesis in nonalcoholic fatty liver disease. Gut 2012;61:1323-9
93. Dias HS, Domingues AL, Cordeiro FT, et al. Associating portal congestive gastropathy and hepatic fibrosis in hepatosplenic mansoni schistosomiasis. Acta Trop 2013;126:240-3
94. Pereira TA, Xie G, Choi SS, et al. Macrophage-derived hedgehog ligands promotes fibrogenic and angiogenic responses in human schistosomiasis mansoni. Liver Int 2013;33:149-61
95. Hirsova P, Ibrahim SH, Bronk SF, et al. Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis. PLoS ONE 2013;8:e70599
96. Grzelak CA, Martelotto LG, Sigglekow ND, et al. The Intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury. J Hepatol 2014;60(1):143-51
97. Guy CD, Suzuki A, Zdanowicz M, et al. Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology 2012;55:1711-21
98. Choi SS, Omenetti A, Syn WK, Diehl AM. The role of hedgehog signaling in fibrogenic liver repair. Int J Biochem Cell Biol 2011;43:238-44
99. Chen Y., Zheng S., Qi D., Guo J. Inhibition of notch signaling by a gamma-secretase inhibitor attenuates hepatic fibrosis in rats. PLoS One 2012;7:e46512
100. Pazzaglia S, Cifaldi L, Saran A, et al. Hedgehog/hyaluronic acid interaction network in nonalcoholic fatty liver disease, fibrosis, and hepatocellular carcinoma. Hepatology 2012;56:1589
101. Witek RP, Yang L, Liu R, et al. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology 2009;136:320-30. e2
102. Xie G, Karaca G, Swiderska-Syn M, et al. Cross-talk between notch and hedgehog regulates hepatic stellate cell fate. Hepatology 2013;58(5):1801-13
103. Chen Y, Choi SS, Michelotti GA, et al. Hedgehog controls hepatic stellate cell fate by regulating metabolism. Gastroenterology 2012;143:1319-29. e1-11
104. Dokucu AI, Ozturk H, Tuncer MC, Yilmaz F. The effects of molsidomine on hypoxia inducible factor alpha and sonic hedgehog in testicular ischemia/ reperfusion injury in rats. Int Urol Nephrol 2009;41:101-8
105. Ciammella P, Ruggieri MP, Galeandro M, et al. Short-course preoperative radiotherapy combined with chemotherapy in resectable locally advanced rectal cancer: local control and quality of life. Radiol Med 2013;118(8):1397-411
106. Wang S, Hyun J, Youn B, Jung Y. Hedgehog signaling regulates the repair response in mouse liver damaged by irradiation. Radiat Res 2013;179:69-75
107. Bian EB, Huang C, Wang H, et al. DNA methylation: new therapeutic implications for hepatic fibrosis. Cell Signal 2013;25:355-8
108. Bian EB, Huang C, Ma TT, et al. DNMT1-mediated PTEN hypermethylation confers hepatic stellate cell activation and liver fibrogenesis in rats. Toxicol Appl Pharmacol 2012;264:13-22
109. He Y, Huang C, Sun X, et al. MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 2012;24:1923-30
110. Tao H, Huang C, Yang JJ, et al. MeCP2 controls the expression of RASAL1 in the hepatic fibrosis in rats. Toxicology 2011;290:327-33
111. Tsukamoto H, Zhu NL, Wang J, et al. Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol 2012;27(Suppl 2):94-8
112. Qin L, Han YP. Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis. Am J Pathol 2010;177:1915-28
113. Mann J, Oakley F, Akiboye F, et al. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ 2007;14:275-85
114. Zou X, Ma W, Solov'yov IA, et al. Recognition of methylated DNA through methyl-CpG binding domain proteins. Nucleic Acids Res 2012;40:2747-58
115. Yang JJ, Tao H, Huang C, et al. DNA methylation and MeCP2 regulation of PTCH1 expression during rats hepatic fibrosis. Cell Signal 2013;25:1202-11
116. Zhang Y, Wu L, Wang Y, et al. Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury. J Biol Chem 2012;287:14851-62
117. Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011;53:209-18
118. Hyun J, Choi SS, Diehl AM, Jung Y. Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKbeta-deficient mouse. J Mol Histol 2014;45(1):103-12